An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer
NCT06315296 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2026-03-03
Summary
This clinical trial tests the effectiveness of an interactive time-restricted diet intervention (txt4fasting) in reducing neurocognitive decline and improving survival outcomes after stereotactic radiosurgery in patients with breast or lung cancer that has spread to the brain (brain metastases). Lung cancer and breast cancer are the two most frequent causes of brain metastases. The diagnosis of brain metastases is associated with poorer survival and tumor-induced and treatment-related side effects. Stereotactic radiosurgery is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. Patients who receive stereotactic radiosurgery for brain metastases may experience less neurocognitive side effects than with other types of brain radiation, but may still be at risk for their brain metastases growing, spreading, or getting worse. Patients with obesity and diabetes have been shown to have worse survival and increased radiation-related side effects. Evidence demonstrates that simply changing meal timing can have a positive impact on multiple health outcomes. Time-restricted eating, or prolonged nighttime fasting, has been proven to have positive effects on heart disease risk reduction, weight control management and chemotherapy side effect reduction. Txt4fasting may be effective in decreasing neurocognitive decline and improving survival outcomes in patients undergoing stereotactic radiosurgery for brain metastases from breast or lung cancer.
Conditions
- Anatomic Stage IV Breast Cancer AJCC v8
- Metastatic Breast Carcinoma
- Metastatic Lung Carcinoma
- Metastatic Malignant Neoplasm in the Brain
- Stage IV Lung Cancer AJCC v8
Interventions
- BEHAVIORAL
-
Behavioral Dietary Intervention
Follow a time-restricted diet
- OTHER
-
Text Message-Based Navigation Intervention
Receive interactive positive reinforcement messages
- OTHER
-
Internet-Based Intervention
Use txt4fasting platform
- BEHAVIORAL
-
Dietary Counseling and Surveillance
Receive counseling calls
- RADIATION
-
Stereotactic Radiosurgery
Undergo SRS
- PROCEDURE
-
Biospecimen Collection
Undergo blood sample collection
- PROCEDURE
-
Magnetic Resonance Imaging
Undergo brain MRI
- OTHER
-
Neurocognitive Assessment
Ancillary studies
- OTHER
-
Questionnaire Administration
Ancillary studies
- OTHER
-
Interview
Ancillary studies
- OTHER
-
Internet-Based Intervention
Use txt4fasting platform
- RADIATION
-
Stereotactic Radiosurgery
Undergo SRS
- OTHER
-
Text Message-Based Navigation Intervention
Receive text messages about healthy eating habits and food suggestions
- PROCEDURE
-
Biospecimen Collection
Undergo blood sample collection
- PROCEDURE
-
Magnetic Resonance Imaging
Undergo brain MRI
- OTHER
-
Neurocognitive Assessment
Ancillary studies
- OTHER
-
Questionnaire Administration
Ancillary studies
- OTHER
-
Interview
Ancillary studies
Sponsors & Collaborators
-
Thomas Jefferson University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-13
- Primary Completion
- 2025-03-15
- Completion
- 2025-10-29
Countries
- United States
Study Locations
More Related Trials
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging
NCT02311556 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression
NCT01604512 ·Status: COMPLETED ·Phase: NA
-
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
NCT02277561 ·Status: WITHDRAWN ·Phase: NA
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer
NCT00362973 ·Status: COMPLETED
-
Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases
NCT03325166 ·Status: TERMINATED ·Phase: PHASE2
-
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging
NCT04514692 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer
NCT01190527 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue
NCT01944215 ·Status: COMPLETED ·Phase: PHASE1
-
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
NCT01712815 ·Status: TERMINATED ·Phase: NA
-
FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
NCT02398773 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
NCT00375830 ·Status: COMPLETED ·Phase: PHASE2
-
PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo
NCT04149353 ·Status: TERMINATED ·Phase: NA
-
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
NCT06072807 ·Status: RECRUITING ·Phase: PHASE4
-
Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival
NCT01261598 ·Status: COMPLETED ·Phase: NA
-
Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
NCT04692103 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Brain Imaging Biomarkers in Patients With Brain Metastasis
NCT04197297 ·Status: RECRUITING ·Phase: PHASE2
-
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
NCT04752267 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
NCT06914999 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
NCT00416455 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer
NCT01627704 ·Status: COMPLETED ·Phase: NA
-
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
NCT04316117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
NCT04525612 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer
NCT06084767 ·Status: RECRUITING ·Phase: NA